magazinelogo

International Journal of Clinical and Experimental Medicine Research

ISSN Print: 2575-7989 Downloads: 193089 Total View: 2346446
Frequency: quarterly ISSN Online: 2575-7970 CODEN: IJCEMH
Email: ijcemr@hillpublisher.com
Article Open Access http://dx.doi.org/10.26855/ijcemr.2024.04.025

Research on the Pathogenic Mechanism of Primary Osteoporosis: Purity & Turbidity Theory in Mongolian Medicine

Tubuxin*, S. Seesregdorj, S. Dorjbat

International School of Mongolian Medicine, Mongolian National University of Medical Sciences (MNUMS), Ulaanbaatar, Mongolia.

*Corresponding author: Tubuxin

Published: May 27,2024

Abstract

To explore the traditional Mongolian medicine's understanding of primary osteoporosis based on the Purity and Turbid theory of Mongolian medicine. Primary osteoporosis was analyzed through the Purity and Turbid theory of Mongolian medicine, and the treatment of primary osteoporosis was explained by traditional Mongolian medicine. Primary osteoporosis is classified as Khey's disease in Mongolian medicine. Traditional Mongolian medicine has a historical understanding of this disease. The principles of treating Khoy's disease and the theory of nourishment for the elderly explain primary osteoporosis. Through the analysis of primary osteoporosis using the theory of Purity and Turbid in Mongolian medicine, it is concluded that traditional Mon-golian medicine offers a unique approach to treating primary osteoporosis. It is concluded that abnormal purity and turbid metabolism directly or indirectly affect bone metabolism and bone quality. Based on the analysis of primary osteoporosis using the Purity and Turbid theory of Mongolian medicine, it is concluded that traditional Mongolian medicine offers a unique approach to treating primary osteoporosis. Abnormal purity and turbid metabolism directly or indirectly affect bone metabolism, resulting in bone pain. General fatigue, waist and leg pain, sweating, and in severe cases fractures, suggest that the Purity and Turbid metabolism theory may be one of the pathogeneses of osteoporosis.

References

[1] Meng Ke Bu & Si Qin Tu. A Primary Investigation of Mongolian Medical Diagnosis and Treatment of Osteoporosis [J]. Journal of Medicine & Pharmacy of Chinese Minorities, 2011. 16(1): 70-71.

[2] Han Ba Gen Na. Bone Diseases of Mongolian Medicine [M]. Hohhot: Inner Mongolia People's Publishing House, Dec. 2006: 79-80.

[3] Ba Ji Ge Mu De. Mongolian Medical Basic Theory [M]: Beijing: The Ethnic Publishing House, Mar. 1986: 55-57.

[4] Cui Jian, Tang Li. Introduction to Traditional Medicine of Chinese Minorities [M]. Beijing: Beijing: Minzu University of China Press, Jun. 2007: 79-80.

[5] Jin Dan. Clinical efficacy of Mongolian medicine in the treatment of primary osteoporosis [J]. Chinese Journal of Ethnic Medicine, 2019, 89(6):3-4.

[6] Tubuxin. Hanbagena Mongolian medicine’s theory of pure and turbid metabolism to explore the pathogenesis of primary osteopo-rosis [J]. Chinese Journal of Ethnic Medicine, 2017, 23 (3): 70-71.

[7] Wang Hongfu. Research Methodology and Technology for Drug Efficacy Study of Osteoporosis [M]. Beijing: People's Medical Publishing House, Sept. 2009: 222.

[8] Wuliji Tegusi. Wuyunsi Rigulin. Bai Yufeng, Wu Linxiang. Experience of Naheya Mongolian Medicine Ginseng and Bamboo Essence Tablets (Mao Haorichagan-5) in the treatment of kidney deficiency [J]. Chinese Journal of Ethnic Medicine, 2014, 23 (5):21-23.

[9] Zhao Feng, Yan Chunlu, Zhang Yaping. Research progress of traditional Chinese medicine in the treatment of osteoporosis [J]. Gansu Medicine, 2016, 35(9):661-663.

[10] Temu Ribagen. Tubu New Mongolian medicine Tonglaga_5-flavor pills on the intervention effect and mechanism of osteoporosis in rats caused by retinoic acid [J]. Journal of Jilin University (Medical Edition), 2014. 40 (4):763-767.

[11] Yang Maoren, Saihan. Discussion on osteoporosis during menopause [J]. Chinese Mongolian Medicine, 2018, 54(4): 31-32.

[12] Qi Shufen, Zhao Jinfu. 78 cases of rheumatoid arthritis treated with Mongolian medicine [J]. Chinese Journal of Ethnic Medicine, 2018, 5(s1):12.

[13] Bai Qingyun. Encyclopedia of Chinese Medicine (Mongolian Medicine) [M]. Chifeng: Inner Mongolia Science and Technology Press, 1986.7: 721.

[14] Observation on the clinical efficacy of Tubuxin, Tonglaga, Se-Seridorji, Mongolian medicine Zhuangxi-4wei powder in the treatment of 60 cases of primary osteoporosis [J]. Chinese Journal of Ethnic Medicine, 2019.12(1):56.

[15] Zhu Fangfei. Research on the estrogenic effects of the traditional Chinese medicine Cistanche deserticola [J]. Journal of Harbin University of Commerce, 2015.31 (1): 1-5.

[16] Xu Xiaoxue. Study on the anti-osteoporosis pharmacodynamics and metabolomics of Roucongrong and its active ingredients [D]. Ningxia Medical University. 2015:78-80.

How to cite this paper

Research on the Pathogenic Mechanism of Primary Osteoporosis: Purity & Turbidity Theory in Mongolian Medicine

How to cite this paper: Tubuxin, S. Seesregdorj, S. Dorjbat. (2024) Research on the Pathogenic Mechanism of Primary Osteoporosis: Purity & Turbidity Theory in Mongolian Medicine. International Journal of Clinical and Experimental Medicine Research8(2), 325-329.

DOI: http://dx.doi.org/10.26855/ijcemr.2024.04.025